Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 31121-93-4
2. Ibuprofen Sodium Salt
3. Sodium Ibuprofen
4. Sodium 2-(4-isobutylphenyl)propionate
5. Sodium 2-[4-(2-methylpropyl)phenyl]propanoate
6. Ibuprofen Sodium Anhydrous
7. P-isobutylhydratropic Acid Sodium Salt
8. Sodium 2-(4-isobutylphenyl)propanoate
9. Ibuprofen (sodium)
10. Sodium;2-[4-(2-methylpropyl)phenyl]propanoate
11. O0pj4uz01u
12. Ibuprofensodiumsalt
13. Einecs 250-477-6
14. Unii-o0pj4uz01u
15. Esprenit (tn)
16. Sodium Ibuprofen Salt
17. Hydratropic Acid, P-isobutyl-, Sodium Salt
18. Benzeneacetic Acid, Alpha-methyl-4-(2-methylpropyl)-, Sodium Salt
19. Schembl139269
20. Chembl1241153
21. Dtxsid4040501
22. Smsf0005424
23. Hy-78131c
24. Sodium2-(4-isobutylphenyl)propanoate
25. Akos015994627
26. Cb08098
27. Hs-0087
28. Sodium 2-(4'-isobutylphenyl)propionate
29. 5264-06-2
30. Bim-0005680.p001
31. Cs-0031024
32. 2-(p-isobutylphenyl)propionic Acid Sodium Salt
33. D08059
34. ((c)i)-ibuprofen-d3, Sodium Salt (
35. A-methyl-d3)
36. W-110791
37. Q27285172
38. Benzeneacetic Acid, .alpha.-methyl-4-(2-methylpropyl)-, Sodium Salt (1:1)
39. Benzeneacetic Acid, .alpha.-methyl-4-(2-methylpropyl)-,sodium Salt
Molecular Weight | 228.26 g/mol |
---|---|
Molecular Formula | C13H17NaO2 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 4 |
Exact Mass | 228.11262406 g/mol |
Monoisotopic Mass | 228.11262406 g/mol |
Topological Polar Surface Area | 40.1 Ų |
Heavy Atom Count | 16 |
Formal Charge | 0 |
Complexity | 208 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
ANALYTICAL
ABOUT THIS PAGE
94
PharmaCompass offers a list of Ibuprofen Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ibuprofen Sodium manufacturer or Ibuprofen Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ibuprofen Sodium manufacturer or Ibuprofen Sodium supplier.
PharmaCompass also assists you with knowing the Ibuprofen Sodium API Price utilized in the formulation of products. Ibuprofen Sodium API Price is not always fixed or binding as the Ibuprofen Sodium Price is obtained through a variety of data sources. The Ibuprofen Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A sodium;2-[4-(2-methylpropyl)phenyl]propanoate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of sodium;2-[4-(2-methylpropyl)phenyl]propanoate, including repackagers and relabelers. The FDA regulates sodium;2-[4-(2-methylpropyl)phenyl]propanoate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. sodium;2-[4-(2-methylpropyl)phenyl]propanoate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of sodium;2-[4-(2-methylpropyl)phenyl]propanoate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A sodium;2-[4-(2-methylpropyl)phenyl]propanoate supplier is an individual or a company that provides sodium;2-[4-(2-methylpropyl)phenyl]propanoate active pharmaceutical ingredient (API) or sodium;2-[4-(2-methylpropyl)phenyl]propanoate finished formulations upon request. The sodium;2-[4-(2-methylpropyl)phenyl]propanoate suppliers may include sodium;2-[4-(2-methylpropyl)phenyl]propanoate API manufacturers, exporters, distributors and traders.
click here to find a list of sodium;2-[4-(2-methylpropyl)phenyl]propanoate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A sodium;2-[4-(2-methylpropyl)phenyl]propanoate DMF (Drug Master File) is a document detailing the whole manufacturing process of sodium;2-[4-(2-methylpropyl)phenyl]propanoate active pharmaceutical ingredient (API) in detail. Different forms of sodium;2-[4-(2-methylpropyl)phenyl]propanoate DMFs exist exist since differing nations have different regulations, such as sodium;2-[4-(2-methylpropyl)phenyl]propanoate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A sodium;2-[4-(2-methylpropyl)phenyl]propanoate DMF submitted to regulatory agencies in the US is known as a USDMF. sodium;2-[4-(2-methylpropyl)phenyl]propanoate USDMF includes data on sodium;2-[4-(2-methylpropyl)phenyl]propanoate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The sodium;2-[4-(2-methylpropyl)phenyl]propanoate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of sodium;2-[4-(2-methylpropyl)phenyl]propanoate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a sodium;2-[4-(2-methylpropyl)phenyl]propanoate Drug Master File in Korea (sodium;2-[4-(2-methylpropyl)phenyl]propanoate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of sodium;2-[4-(2-methylpropyl)phenyl]propanoate. The MFDS reviews the sodium;2-[4-(2-methylpropyl)phenyl]propanoate KDMF as part of the drug registration process and uses the information provided in the sodium;2-[4-(2-methylpropyl)phenyl]propanoate KDMF to evaluate the safety and efficacy of the drug.
After submitting a sodium;2-[4-(2-methylpropyl)phenyl]propanoate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their sodium;2-[4-(2-methylpropyl)phenyl]propanoate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of sodium;2-[4-(2-methylpropyl)phenyl]propanoate suppliers with KDMF on PharmaCompass.
A sodium;2-[4-(2-methylpropyl)phenyl]propanoate written confirmation (sodium;2-[4-(2-methylpropyl)phenyl]propanoate WC) is an official document issued by a regulatory agency to a sodium;2-[4-(2-methylpropyl)phenyl]propanoate manufacturer, verifying that the manufacturing facility of a sodium;2-[4-(2-methylpropyl)phenyl]propanoate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting sodium;2-[4-(2-methylpropyl)phenyl]propanoate APIs or sodium;2-[4-(2-methylpropyl)phenyl]propanoate finished pharmaceutical products to another nation, regulatory agencies frequently require a sodium;2-[4-(2-methylpropyl)phenyl]propanoate WC (written confirmation) as part of the regulatory process.
click here to find a list of sodium;2-[4-(2-methylpropyl)phenyl]propanoate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing sodium;2-[4-(2-methylpropyl)phenyl]propanoate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for sodium;2-[4-(2-methylpropyl)phenyl]propanoate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture sodium;2-[4-(2-methylpropyl)phenyl]propanoate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain sodium;2-[4-(2-methylpropyl)phenyl]propanoate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a sodium;2-[4-(2-methylpropyl)phenyl]propanoate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of sodium;2-[4-(2-methylpropyl)phenyl]propanoate suppliers with NDC on PharmaCompass.
sodium;2-[4-(2-methylpropyl)phenyl]propanoate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of sodium;2-[4-(2-methylpropyl)phenyl]propanoate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right sodium;2-[4-(2-methylpropyl)phenyl]propanoate GMP manufacturer or sodium;2-[4-(2-methylpropyl)phenyl]propanoate GMP API supplier for your needs.
A sodium;2-[4-(2-methylpropyl)phenyl]propanoate CoA (Certificate of Analysis) is a formal document that attests to sodium;2-[4-(2-methylpropyl)phenyl]propanoate's compliance with sodium;2-[4-(2-methylpropyl)phenyl]propanoate specifications and serves as a tool for batch-level quality control.
sodium;2-[4-(2-methylpropyl)phenyl]propanoate CoA mostly includes findings from lab analyses of a specific batch. For each sodium;2-[4-(2-methylpropyl)phenyl]propanoate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
sodium;2-[4-(2-methylpropyl)phenyl]propanoate may be tested according to a variety of international standards, such as European Pharmacopoeia (sodium;2-[4-(2-methylpropyl)phenyl]propanoate EP), sodium;2-[4-(2-methylpropyl)phenyl]propanoate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (sodium;2-[4-(2-methylpropyl)phenyl]propanoate USP).